Researchers at ETH Zurich and the University Hospital of Zurich launched the RCPatch, a degradable 3D-printed cardiac patch designed to both seal and regenerate damaged heart tissue, featuring a cell-laden hydrogel embedded in a printed scaffold. The device combined a fine sealing mesh, a lattice scaffold made from a biodegradable polymer and a hydrogel carrying living heart muscle cells, allowing structural support while promoting tissue ingrowth.
In pig models the patch withstood left-ventricle blood pressure, closed artificial defects and prevented bleeding during initial preclinical trials, demonstrating functional repair under physiological conditions. By degrading as native cells integrate, the RCPatch aims to avoid permanent foreign-body complications like calcification or thrombosis and points to a trend of bioresorbable implants that support regeneration rather than permanent replacement.
Degradable Cardiac Repair Patches
ETH Zurich Introduced the RCPatch to Repair Hearts
Trend Themes
-
Bioresorbable Regenerative Implants — A move from permanent prosthetics to implants that gradually degrade as native tissue replaces them could reduce long-term complications and enable temporally targeted healing.
-
Cell Laden 3D Printing — Embedding living cells within printed scaffolds creates the potential for patient-specific, functional tissue constructs that integrate structurally and biologically with host organs.
-
Functional Sealing with Structural Support — Combining ultra-fine sealing meshes with load-bearing lattice scaffolds offers the ability to both prevent acute failure (e.g., bleeding) and support mechanical loads during regeneration.
Industry Implications
-
Cardiac Surgery — Surgeons could access patches that provide immediate hemostasis and mid-term mechanical support while promoting myocardial regeneration, changing perioperative repair strategies.
-
Medical Device Manufacturing — Manufacturers may pivot toward producing composite, biodegradable devices that integrate biologics and require new standards for sterilization, storage, and regulatory validation.
-
Bioprinting and Tissue Engineering — Researchers and startups in bioprinting might scale platforms for printing cell-laden, load-bearing constructs tailored to organ-specific mechanical and biological demands.